Nathan A - Search Results

1

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.

Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L; Dual Antiplatelet Therapy Study Investigators. Resor CD, et al. Among authors: nathan a. Circulation. 2016 Oct 4;134(14):989-998. doi: 10.1161/CIRCULATIONAHA.116.024531. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576774 Free PMC article. Clinical Trial.

2

Diabetic heart disease and interventional cardiology: how can clinical outcomes be improved? Revascularization guided by hemodynamic parameters (fractional flow reserve).

Nathan A, Mauri L. Nathan A, et al. Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):432-4. doi: 10.1016/j.rec.2012.12.013. Epub 2013 Apr 11. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24776044 No abstract available.

3

Adherence to dual antiplatelet therapy after coronary stenting: a systematic review.

Czarny MJ, Nathan AS, Yeh RW, Mauri L. Czarny MJ, et al. Clin Cardiol. 2014 Aug;37(8):505-13. doi: 10.1002/clc.22289. Epub 2014 May 2. Clin Cardiol. 2014. PMID: 24797884 Free PMC article. Review.

4

The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.

Nathan AS, Sen S, Yeh RW. Nathan AS, et al. Expert Opin Drug Saf. 2017 May;16(5):561-572. doi: 10.1080/14740338.2017.1315101. Epub 2017 Apr 26. Expert Opin Drug Saf. 2017. PMID: 28387542 Review.

5

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

Goli RR, Contractor MM, Nathan A, Tuteja S, Kobayashi T, Giri J. Goli RR, et al. Among authors: nathan a. Curr Atheroscler Rep. 2017 Nov 4;19(12):56. doi: 10.1007/s11883-017-0698-2. Curr Atheroscler Rep. 2017. PMID: 29103068 Review.

6

Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest.

Nathan AS, Shah RM, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J. Nathan AS, et al. Circ Cardiovasc Interv. 2019 Apr;12(4):e007564. doi: 10.1161/CIRCINTERVENTIONS.118.007564. Circ Cardiovasc Interv. 2019. PMID: 30998398 Free PMC article.

7

Hospital-Specific Mortality for Acute Myocardial Infarction Versus Emergency Percutaneous Coronary Intervention in New York State.

Nathan AS, Khatana SAM, Yeh RW, Groeneveld PW, Giri J. Nathan AS, et al. JACC Cardiovasc Interv. 2019 May 13;12(9):898-899. doi: 10.1016/j.jcin.2019.02.045. JACC Cardiovasc Interv. 2019. PMID: 31072516 Free PMC article. No abstract available.

8

Association of Medicaid Expansion With Cardiovascular Mortality.

Khatana SAM, Bhatla A, Nathan AS, Giri J, Shen C, Kazi DS, Yeh RW, Groeneveld PW. Khatana SAM, et al. Among authors: nathan as. JAMA Cardiol. 2019 Jul 1;4(7):671-679. doi: 10.1001/jamacardio.2019.1651. JAMA Cardiol. 2019. PMID: 31166575 Free PMC article.

9

Paving a Road to PCI Quality With Good Intentions and Rigorous Statistics: Still Not Enough?

Yeh RW, Nathan AS. Yeh RW, et al. JACC Cardiovasc Interv. 2019 Oct 14;12(19):1976-1978. doi: 10.1016/j.jcin.2019.08.012. JACC Cardiovasc Interv. 2019. PMID: 31601392 Free article. No abstract available.

10

Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.

Tuteja S, Glick H, Matthai W, Nachamkin I, Nathan A, Monono K, Carcuffe C, Maslowski K, Chang G, Kobayashi T, Anwaruddin S, Hirshfeld J, Wilensky RL, Herrmann HC, Kolansky DM, Rader DJ, Giri J. Tuteja S, et al. Among authors: nathan a. Circ Genom Precis Med. 2020 Feb;13(1):e002640. doi: 10.1161/CIRCGEN.119.002640. Epub 2020 Jan 12. Circ Genom Precis Med. 2020. PMID: 31928229 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page